Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

Hair loss requires customized treatments based on its various causes and types.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Cryotherapy may be an effective and simple treatment for mild hair loss with few side effects.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.